. Gross view of the excised mass after formalin fixation. The mass is well delineated by a band of white tissue, and the cut surface, which is white and gelatinous, is divided into large lobules by thin septa. Fig. 2 . The neoplasm has several lobules separated by thin fibrous septa. The lobules contain abundant extracellular matrix.
HE. ×10. Fig. 3 . Fibrous capsule and blue-stained extracellular matrix. Tumour cells have a fusiform appearance (arrowheads). Nuclei are counterstained with nuclear red. Alcian blue, pH 2·5. ×40. Fig. 4 . Immunoreactivity with anti-vimentin polyclonal antibody is observed in fusiform and stellate cells whose nuclei are obscured by the deep immunolabelling of the cytoplasm. ABC. ×40. Fig. 5 . Immunoreactivity with anti-S100 protein polyclonal antibody is observed in the nuclei and cytoplasm of isolated fusiform and stellate cells (arrows). Macrophages with dark blue, pyknotic nuclei and vacuolated cytoplasm are also observed (arrowheads). ABC. ×40. (Fig. 3) . The nuclei were round to elongate, uniform et al., 1994), the immunohistochemical phenotype of the tumour cells described here supports the and without visible nucleoli. The margins of the mass were composed of well-vascularized fibrous diagnosis of myxoma. Thus, vimentin is the intermediate filament protein characteristic of normal tissue, with or without lymphocytic infiltration.
Immunohistochemically, the tumour cells re-and tumoral mesenchymal cells and is detected in myxomas (Enzinger and Weiss, 1988) . Other acted with vimentin and S100 protein antibodies exclusively. Immunoreactivity with vimentin anti-markers have been detected in myxomas at different locations. Thus, in man, some odontogenic myxbody was observed in the cytoplasm of the majority (c. 95%) of tumour cells, as well as in vascular omas, but not other oral myxoid lesions, may express S100 protein (Lombardi et al., 1995) . Also endothelial cells and fibroblasts (Fig. 4) ; immunoreactivity with S100 protein antibody was in man, cardiac myxomas (Rubin et al., 1995;
Deshpande et al., 1996) and a myxoma of the breast found in both the nucleus and cytoplasm of a minority (less than 10%) of cells (Fig. 5) , 1996) and alpha of either human beings (Fechner and Mills, 1993) or domestic animal species (Slayter et al., 1994) . smooth muscle actin (Horie et al., 1995) have been detected in some myxomas. These findings suggest However, myxomas of joints were described previously in four dogs. The first three cases were the presence of totipotential primitive mesenchymal cells among the more mature fibroblastic reported as joint lesions which did not belong to any of the existing categories of tumours or tumour-cells, which express only vimentin (Lombardi et al.,
1995; Rubin et al., 1995; Deshpande et al., 1996). like lesions of animal joints (Pool, 1990); they were centred in the synovial linings and the term "myxSeveral types of soft tissue tumour may have areas of myxoid change or myxoid variants (Enzinger and oma of the synovium" was used. Of the three animals, two were mature Dobermann pinschers Weiss, 1988; Gross et al., 1992) and true myxomas must be distinguished from them. Among such (a male and a female), each with a single affected joint (stifle), and one was a 9-year-old English tumours, those with a keratin-negative, vimentinpositive and S100 protein-positive immunospaniel with two adjacent ipsilateral apophyseal joints affected in the cervical spine (C-2 and C-phenotype include lipomas and liposarcomas, melanomas, mesenchymomas and schwannomas 3). Two of the cases described showed locally infiltrative neoplastic growth, the myxoid tumour (Enzinger and Weiss, 1988; Pérez et al., 1996) .
Liposarcomas and mesenchymomas have been detissue extending beyond the fibrous layer of the joint capsule and infiltrating along fascial planes scribed in joint tissues (Slayter et al., 1994) ; both, however, are neoplasms with histological charof adjacent musculature. The third case, a male Dobermann pinscher, resembled the case described acteristics of malignancy. In addition, liposarcoma is characterized by the presence of atypical lipohere, in which no infiltrative growth was observed macroscopically and no sign of recurrence ap-blasts, and mesenchymoma by the presence of at least two independent sarcoma cell types (e.g., peared within 2 years of surgical removal.
The fourth recorded case of joint myxoma, de-osteosarcomatous and liposarcomatous) in a fibromatous-like pattern (Slayter et al., 1994) . An scribed by Griffon et al. (1994) , also had features similar to those of the present case; it arose, how-unusual variant of benign schwannoma is myxoid schwannoma; this soft tissue tumour, located in the ever, from the joint capsule. The dog was a 10-year-old female Alaskan malamute with left front digits of dogs, has a multilobular configuration reminiscent of Pacinian corpuscles and is composed limb lameness; the tumour, which was excised, originated from the left radiocarpal joint capsule of small spindle and stellate cells forming loose, concentric swirls in an abundant background of and was identified histopathologically as a myxoma. Tumour recurrence was not evident during a 4-mucin (Gross et al., 1992) . It is easily confused with myxoma, especially in view of the immunoyear follow-up period.
In addition to gross and microscopical similarities phenotype of myxoma tumour cells. However, areas of spindle (Antoni type A) or polygonal (Anto myxomas at other locations (Enzinger and Weiss, 1988; Hendrick et al., 1998) , and to the clinical toni type B) cells, or both types of area, as well as serpentine nuclei, are found in all variants of and pathological similarities to previously reported cases of canine joint myxoma (Pool, 1990; Griffon schwannomas (Gross et al., 1992) . Hsu, S. M., Raine, L. and Fanger, H. (1981) . The use
